Teachers Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Teachers Advisors’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$4.31M	Sell	356,889 -3,400	-0.9%	-$50.1K	0.01%	1515
2018 Q4	$4.52M	Buy	360,289 +5,048	+1%	+$69.7K	0.01%	1370
2018 Q3	$5.27M	Sell	355,241 -388	-0.1%	-$6.1K	0.01%	1416
2018 Q2	$5.99M	Buy	355,629 +21,056	+6%	+$409K	0.01%	1330
2018 Q1	$7.66M	Buy	334,573 +199,174	+147%	+$4.43M	0.01%	1127
2017 Q4	$3.5M	Buy	135,399 +101,026	+294%	+$2.03M	﹤0.01%	1531
2017 Q3	$507K	Hold	34,373	–	–	﹤0.01%	2581
2017 Q2	$480K	Buy	34,373 +3,446	+11%	+$50.8K	﹤0.01%	2612
2017 Q1	$528K	Buy	30,927 +6,303	+26%	+$75.6K	﹤0.01%	2510
2016 Q4	$253K	Hold	24,624	–	–	﹤0.01%	2840
2016 Q3	$249K	Hold	24,624	–	–	﹤0.01%	2792
2016 Q2	$277K	Buy	24,624 +2,356	+11%	+$30K	﹤0.01%	2728
2016 Q1	$304K	Hold	22,268	–	–	﹤0.01%	2609
2015 Q4	$422K	Hold	22,268	–	–	﹤0.01%	2509
2015 Q3	$418K	Hold	22,268	–	–	﹤0.01%	2498
2015 Q2	$332K	Buy	+22,268	New	+$339K	﹤0.01%	2778
2014 Q2	–	Sell	-6,750	Closed	-$91K	–	3196
2014 Q1	$91K	Buy	+6,750	New	+$95.3K	﹤0.01%	3036

Other funds holding CNCE

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Teachers Advisors's CNCE Position: Q1 2019 in Review

Teachers Advisors reduced its Concert Pharmaceuticals, Inc. (CNCE) stake by 0.94% in Q1 2019, selling an estimated $50.1K and leaving 356,889 shares worth $4.31M. The position accounts for 0.01% of the portfolio, ranked #1515.

Teachers Advisors first reported a position in CNCE in Q1 2014 and has held it in 17 quarters since. The position peaked at $7.66M in Q1 2018. 92 funds tracked by Wall St. Rank hold CNCE as of Q1 2019.

Teachers Advisors held 356,889 shares of Concert Pharmaceuticals, Inc. worth $4.31M as of Q1 2019.
Teachers Advisors sold 3,400 Concert Pharmaceuticals, Inc. shares in Q1 2019, an estimated $50.1K.
Concert Pharmaceuticals, Inc. made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1515 holding.
Teachers Advisors first reported a position in Concert Pharmaceuticals, Inc. in Q1 2014 and has held it in 17 quarters since.
Teachers Advisors's Concert Pharmaceuticals, Inc. position peaked at $7.66M in Q1 2018.
92 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.